Dance movement therapy for depression
Background Depression is a debilitating condition affecting more than 350 million people worldwide (WHO 2012) with a limited number of evidence‐based treatments. Drug treatments may be inappropriate due to side effects and cost, and not everyone can use talking therapies.There is a need for evidence...
Gespeichert in:
| Veröffentlicht in: | Cochrane database of systematic reviews 2015-02, Vol.2016 (6), p.CD009895-CD009895 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | CD009895 |
|---|---|
| container_issue | 6 |
| container_start_page | CD009895 |
| container_title | Cochrane database of systematic reviews |
| container_volume | 2016 |
| creator | Meekums, Bonnie Karkou, Vicky Nelson, E Andrea Meekums, Bonnie |
| description | Background
Depression is a debilitating condition affecting more than 350 million people worldwide (WHO 2012) with a limited number of evidence‐based treatments. Drug treatments may be inappropriate due to side effects and cost, and not everyone can use talking therapies.There is a need for evidence‐based treatments that can be applied across cultures and with people who find it difficult to verbally articulate thoughts and feelings. Dance movement therapy (DMT) is used with people from a range of cultural and intellectual backgrounds, but effectiveness remains unclear.
Objectives
To examine the effects of DMT for depression with or without standard care, compared to no treatment or standard care alone, psychological therapies, drug treatment, or other physical interventions. Also, to compare the effectiveness of different DMT approaches.
Search methods
The Cochrane Depression, Anxiety and Neurosis Review Group's Specialised Register (CCDANCTR‐Studies and CCDANCTR‐References) and CINAHL were searched (to 2 Oct 2014) together with the World Health Organization's International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov. The review authors also searched the Allied and Complementary Medicine Database (AMED), the Education Resources Information Center (ERIC) and Dissertation s (to August 2013), handsearched bibliographies, contacted professional associations, educational programmes and dance therapy experts worldwide.
Selection criteria
Inclusion criteria were: randomised controlled trials (RCTs) studying outcomes for people of any age with depression as defined by the trialist, with at least one group being DMT. DMT was defined as: participatory dance movement with clear psychotherapeutic intent, facilitated by an individual with a level of training that could be reasonably expected within the country in which the trial was conducted. For example, in the USA this would either be a trainee, or qualified and credentialed by the American Dance Therapy Association (ADTA). In the UK, the therapist would either be in training with, or accredited by, the Association for Dance Movement Psychotherapy (ADMP, UK). Similar professional bodies exist in Europe, but in some countries (e.g. China) where the profession is in development, a lower level of qualification would mirror the situation some decades previously in the USA or UK. Hence, the review authors accepted a relevant professional qualification (e.g. nursing or psychodynamic therapies) pl |
| doi_str_mv | 10.1002/14651858.CD009895.pub2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8928931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1660412512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4732-a62937f8df6868071ef088c35a6ba78ee448daee6aa4f73f83c99129fe7723573</originalsourceid><addsrcrecordid>eNqFUElLAzEUDqLYWv0LpRfBy9QsM1kugrZuUPCi4C2kmRc7MjMZk7bSf--ULlQvnt6D923vQ6hP8JBgTK9JyjMiMzkcjTFWUmXDZjGlR6jbHlSSKvZ-fLB30FmMnxgzRYg8RR2acZVJQbrocmxqC4PKL6GCej6YzyCYZjVwPgxyaALEWPj6HJ04U0a42M4eenu4fx09JZOXx-fR7SSxqWA0MZwqJpzMHZdcYkHAYSktywyfGiEB0lTmBoAbkzrBnGRWKUKVAyEoywTroZuNbvtMBbltEwVT6iYUlQkr7U2hf1_qYqY__FJLRaVipBW42goE_7WAONdVES2UpanBL6ImnOOU0IzQFso3UBt8jAHc3oZgve5Y7zrWu47X5mti_zDknrYrtQXcbQDfRQkrbb2dhdb_H90_Lj8pSIy1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1660412512</pqid></control><display><type>article</type><title>Dance movement therapy for depression</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><source>Cochrane Library</source><creator>Meekums, Bonnie ; Karkou, Vicky ; Nelson, E Andrea ; Meekums, Bonnie</creator><creatorcontrib>Meekums, Bonnie ; Karkou, Vicky ; Nelson, E Andrea ; Meekums, Bonnie</creatorcontrib><description>Background
Depression is a debilitating condition affecting more than 350 million people worldwide (WHO 2012) with a limited number of evidence‐based treatments. Drug treatments may be inappropriate due to side effects and cost, and not everyone can use talking therapies.There is a need for evidence‐based treatments that can be applied across cultures and with people who find it difficult to verbally articulate thoughts and feelings. Dance movement therapy (DMT) is used with people from a range of cultural and intellectual backgrounds, but effectiveness remains unclear.
Objectives
To examine the effects of DMT for depression with or without standard care, compared to no treatment or standard care alone, psychological therapies, drug treatment, or other physical interventions. Also, to compare the effectiveness of different DMT approaches.
Search methods
The Cochrane Depression, Anxiety and Neurosis Review Group's Specialised Register (CCDANCTR‐Studies and CCDANCTR‐References) and CINAHL were searched (to 2 Oct 2014) together with the World Health Organization's International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov. The review authors also searched the Allied and Complementary Medicine Database (AMED), the Education Resources Information Center (ERIC) and Dissertation s (to August 2013), handsearched bibliographies, contacted professional associations, educational programmes and dance therapy experts worldwide.
Selection criteria
Inclusion criteria were: randomised controlled trials (RCTs) studying outcomes for people of any age with depression as defined by the trialist, with at least one group being DMT. DMT was defined as: participatory dance movement with clear psychotherapeutic intent, facilitated by an individual with a level of training that could be reasonably expected within the country in which the trial was conducted. For example, in the USA this would either be a trainee, or qualified and credentialed by the American Dance Therapy Association (ADTA). In the UK, the therapist would either be in training with, or accredited by, the Association for Dance Movement Psychotherapy (ADMP, UK). Similar professional bodies exist in Europe, but in some countries (e.g. China) where the profession is in development, a lower level of qualification would mirror the situation some decades previously in the USA or UK. Hence, the review authors accepted a relevant professional qualification (e.g. nursing or psychodynamic therapies) plus a clear description of the treatment that would indicate its adherence to published guidelines including Levy 1992, ADMP UK 2015, Meekums 2002, and Karkou 2006.
Data collection and analysis
Study methodological quality was evaluated and data were extracted independently by the first two review authors using a data extraction form, the third author acting as an arbitrator.
Main results
Three studies totalling 147 participants (107 adults and 40 adolescents) met the inclusion criteria. Seventy‐four participants took part in DMT treatment, while 73 comprised the control groups. Two studies included male and female adults with depression. One of these studies included outpatient participants; the other study was conducted with inpatients at an urban hospital. The third study reported findings with female adolescents in a middle‐school setting. All included studies collected continuous data using two different depression measures: the clinician‐completed Hamilton Depression Rating Scale (HAM‐D); and the Symptom Checklist‐90‐R (SCL‐90‐R) (self‐rating scale).
Statistical heterogeneity was identified between the three studies. There was no reliable effect of DMT on depression (SMD ‐0.67 95% CI ‐1.40 to 0.05; very low quality evidence). A planned subgroup analysis indicated a positive effect in adults, across two studies, 107 participants, but this failed to meet clinical significance (SMD ‐7.33 95% CI ‐9.92 to ‐4.73).
One adult study reported drop‐out rates, found to be non‐significant with an odds ratio of 1.82 [95% CI 0.35 to 9.45]; low quality evidence. One study measured social functioning, demonstrating a large positive effect (MD ‐6.80 95 % CI ‐11.44 to ‐2.16; very low quality evidence), but this result was imprecise. One study showed no effect in either direction for quality of life (0.30 95% CI ‐0.60 to 1.20; low quality evidence) or self esteem (1.70 95% CI ‐2.36 to 5.76; low quality evidence).
Authors' conclusions
The low‐quality evidence from three small trials with 147 participants does not allow any firm conclusions to be drawn regarding the effectiveness of DMT for depression. Larger trials of high methodological quality are needed to assess DMT for depression, with economic analyses and acceptability measures and for all age groups.</description><identifier>ISSN: 1469-493X</identifier><identifier>EISSN: 1469-493X</identifier><identifier>DOI: 10.1002/14651858.CD009895.pub2</identifier><identifier>PMID: 25695871</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Adolescent ; Adult ; Antidepressive Agents ; Antidepressive Agents - therapeutic use ; Child & Adolescent ; Child health ; Complementary & alternative medicine ; Condition ; Dance Therapy ; Dance Therapy - methods ; Depression ; Depression - therapy ; Depressive disorder ; Depressive disorder, major ; Depressive disorders & major depression ; Empathy ; Female ; Humans ; Intervention ; Male ; Medicine General & Introductory Medical Sciences ; Mental health ; Mood disorders ; Movement ; Older people ; Other ; Population ; Psychotherapy ; Randomized Controlled Trials as Topic ; Sensation</subject><ispartof>Cochrane database of systematic reviews, 2015-02, Vol.2016 (6), p.CD009895-CD009895</ispartof><rights>Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4732-a62937f8df6868071ef088c35a6ba78ee448daee6aa4f73f83c99129fe7723573</citedby><cites>FETCH-LOGICAL-c4732-a62937f8df6868071ef088c35a6ba78ee448daee6aa4f73f83c99129fe7723573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25695871$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meekums, Bonnie</creatorcontrib><creatorcontrib>Karkou, Vicky</creatorcontrib><creatorcontrib>Nelson, E Andrea</creatorcontrib><creatorcontrib>Meekums, Bonnie</creatorcontrib><title>Dance movement therapy for depression</title><title>Cochrane database of systematic reviews</title><addtitle>Cochrane Database Syst Rev</addtitle><description>Background
Depression is a debilitating condition affecting more than 350 million people worldwide (WHO 2012) with a limited number of evidence‐based treatments. Drug treatments may be inappropriate due to side effects and cost, and not everyone can use talking therapies.There is a need for evidence‐based treatments that can be applied across cultures and with people who find it difficult to verbally articulate thoughts and feelings. Dance movement therapy (DMT) is used with people from a range of cultural and intellectual backgrounds, but effectiveness remains unclear.
Objectives
To examine the effects of DMT for depression with or without standard care, compared to no treatment or standard care alone, psychological therapies, drug treatment, or other physical interventions. Also, to compare the effectiveness of different DMT approaches.
Search methods
The Cochrane Depression, Anxiety and Neurosis Review Group's Specialised Register (CCDANCTR‐Studies and CCDANCTR‐References) and CINAHL were searched (to 2 Oct 2014) together with the World Health Organization's International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov. The review authors also searched the Allied and Complementary Medicine Database (AMED), the Education Resources Information Center (ERIC) and Dissertation s (to August 2013), handsearched bibliographies, contacted professional associations, educational programmes and dance therapy experts worldwide.
Selection criteria
Inclusion criteria were: randomised controlled trials (RCTs) studying outcomes for people of any age with depression as defined by the trialist, with at least one group being DMT. DMT was defined as: participatory dance movement with clear psychotherapeutic intent, facilitated by an individual with a level of training that could be reasonably expected within the country in which the trial was conducted. For example, in the USA this would either be a trainee, or qualified and credentialed by the American Dance Therapy Association (ADTA). In the UK, the therapist would either be in training with, or accredited by, the Association for Dance Movement Psychotherapy (ADMP, UK). Similar professional bodies exist in Europe, but in some countries (e.g. China) where the profession is in development, a lower level of qualification would mirror the situation some decades previously in the USA or UK. Hence, the review authors accepted a relevant professional qualification (e.g. nursing or psychodynamic therapies) plus a clear description of the treatment that would indicate its adherence to published guidelines including Levy 1992, ADMP UK 2015, Meekums 2002, and Karkou 2006.
Data collection and analysis
Study methodological quality was evaluated and data were extracted independently by the first two review authors using a data extraction form, the third author acting as an arbitrator.
Main results
Three studies totalling 147 participants (107 adults and 40 adolescents) met the inclusion criteria. Seventy‐four participants took part in DMT treatment, while 73 comprised the control groups. Two studies included male and female adults with depression. One of these studies included outpatient participants; the other study was conducted with inpatients at an urban hospital. The third study reported findings with female adolescents in a middle‐school setting. All included studies collected continuous data using two different depression measures: the clinician‐completed Hamilton Depression Rating Scale (HAM‐D); and the Symptom Checklist‐90‐R (SCL‐90‐R) (self‐rating scale).
Statistical heterogeneity was identified between the three studies. There was no reliable effect of DMT on depression (SMD ‐0.67 95% CI ‐1.40 to 0.05; very low quality evidence). A planned subgroup analysis indicated a positive effect in adults, across two studies, 107 participants, but this failed to meet clinical significance (SMD ‐7.33 95% CI ‐9.92 to ‐4.73).
One adult study reported drop‐out rates, found to be non‐significant with an odds ratio of 1.82 [95% CI 0.35 to 9.45]; low quality evidence. One study measured social functioning, demonstrating a large positive effect (MD ‐6.80 95 % CI ‐11.44 to ‐2.16; very low quality evidence), but this result was imprecise. One study showed no effect in either direction for quality of life (0.30 95% CI ‐0.60 to 1.20; low quality evidence) or self esteem (1.70 95% CI ‐2.36 to 5.76; low quality evidence).
Authors' conclusions
The low‐quality evidence from three small trials with 147 participants does not allow any firm conclusions to be drawn regarding the effectiveness of DMT for depression. Larger trials of high methodological quality are needed to assess DMT for depression, with economic analyses and acceptability measures and for all age groups.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antidepressive Agents</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Child & Adolescent</subject><subject>Child health</subject><subject>Complementary & alternative medicine</subject><subject>Condition</subject><subject>Dance Therapy</subject><subject>Dance Therapy - methods</subject><subject>Depression</subject><subject>Depression - therapy</subject><subject>Depressive disorder</subject><subject>Depressive disorder, major</subject><subject>Depressive disorders & major depression</subject><subject>Empathy</subject><subject>Female</subject><subject>Humans</subject><subject>Intervention</subject><subject>Male</subject><subject>Medicine General & Introductory Medical Sciences</subject><subject>Mental health</subject><subject>Mood disorders</subject><subject>Movement</subject><subject>Older people</subject><subject>Other</subject><subject>Population</subject><subject>Psychotherapy</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Sensation</subject><issn>1469-493X</issn><issn>1469-493X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>RWY</sourceid><sourceid>EIF</sourceid><recordid>eNqFUElLAzEUDqLYWv0LpRfBy9QsM1kugrZuUPCi4C2kmRc7MjMZk7bSf--ULlQvnt6D923vQ6hP8JBgTK9JyjMiMzkcjTFWUmXDZjGlR6jbHlSSKvZ-fLB30FmMnxgzRYg8RR2acZVJQbrocmxqC4PKL6GCej6YzyCYZjVwPgxyaALEWPj6HJ04U0a42M4eenu4fx09JZOXx-fR7SSxqWA0MZwqJpzMHZdcYkHAYSktywyfGiEB0lTmBoAbkzrBnGRWKUKVAyEoywTroZuNbvtMBbltEwVT6iYUlQkr7U2hf1_qYqY__FJLRaVipBW42goE_7WAONdVES2UpanBL6ImnOOU0IzQFso3UBt8jAHc3oZgve5Y7zrWu47X5mti_zDknrYrtQXcbQDfRQkrbb2dhdb_H90_Lj8pSIy1</recordid><startdate>20150219</startdate><enddate>20150219</enddate><creator>Meekums, Bonnie</creator><creator>Karkou, Vicky</creator><creator>Nelson, E Andrea</creator><creator>Meekums, Bonnie</creator><general>John Wiley & Sons, Ltd</general><scope>7PX</scope><scope>RWY</scope><scope>ZYTZH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150219</creationdate><title>Dance movement therapy for depression</title><author>Meekums, Bonnie ; Karkou, Vicky ; Nelson, E Andrea ; Meekums, Bonnie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4732-a62937f8df6868071ef088c35a6ba78ee448daee6aa4f73f83c99129fe7723573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antidepressive Agents</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Child & Adolescent</topic><topic>Child health</topic><topic>Complementary & alternative medicine</topic><topic>Condition</topic><topic>Dance Therapy</topic><topic>Dance Therapy - methods</topic><topic>Depression</topic><topic>Depression - therapy</topic><topic>Depressive disorder</topic><topic>Depressive disorder, major</topic><topic>Depressive disorders & major depression</topic><topic>Empathy</topic><topic>Female</topic><topic>Humans</topic><topic>Intervention</topic><topic>Male</topic><topic>Medicine General & Introductory Medical Sciences</topic><topic>Mental health</topic><topic>Mood disorders</topic><topic>Movement</topic><topic>Older people</topic><topic>Other</topic><topic>Population</topic><topic>Psychotherapy</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Sensation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meekums, Bonnie</creatorcontrib><creatorcontrib>Karkou, Vicky</creatorcontrib><creatorcontrib>Nelson, E Andrea</creatorcontrib><creatorcontrib>Meekums, Bonnie</creatorcontrib><collection>Wiley-Blackwell Cochrane Library</collection><collection>Cochrane Library</collection><collection>Cochrane Library (Open Aceess)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cochrane database of systematic reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meekums, Bonnie</au><au>Karkou, Vicky</au><au>Nelson, E Andrea</au><au>Meekums, Bonnie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dance movement therapy for depression</atitle><jtitle>Cochrane database of systematic reviews</jtitle><addtitle>Cochrane Database Syst Rev</addtitle><date>2015-02-19</date><risdate>2015</risdate><volume>2016</volume><issue>6</issue><spage>CD009895</spage><epage>CD009895</epage><pages>CD009895-CD009895</pages><issn>1469-493X</issn><eissn>1469-493X</eissn><abstract>Background
Depression is a debilitating condition affecting more than 350 million people worldwide (WHO 2012) with a limited number of evidence‐based treatments. Drug treatments may be inappropriate due to side effects and cost, and not everyone can use talking therapies.There is a need for evidence‐based treatments that can be applied across cultures and with people who find it difficult to verbally articulate thoughts and feelings. Dance movement therapy (DMT) is used with people from a range of cultural and intellectual backgrounds, but effectiveness remains unclear.
Objectives
To examine the effects of DMT for depression with or without standard care, compared to no treatment or standard care alone, psychological therapies, drug treatment, or other physical interventions. Also, to compare the effectiveness of different DMT approaches.
Search methods
The Cochrane Depression, Anxiety and Neurosis Review Group's Specialised Register (CCDANCTR‐Studies and CCDANCTR‐References) and CINAHL were searched (to 2 Oct 2014) together with the World Health Organization's International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov. The review authors also searched the Allied and Complementary Medicine Database (AMED), the Education Resources Information Center (ERIC) and Dissertation s (to August 2013), handsearched bibliographies, contacted professional associations, educational programmes and dance therapy experts worldwide.
Selection criteria
Inclusion criteria were: randomised controlled trials (RCTs) studying outcomes for people of any age with depression as defined by the trialist, with at least one group being DMT. DMT was defined as: participatory dance movement with clear psychotherapeutic intent, facilitated by an individual with a level of training that could be reasonably expected within the country in which the trial was conducted. For example, in the USA this would either be a trainee, or qualified and credentialed by the American Dance Therapy Association (ADTA). In the UK, the therapist would either be in training with, or accredited by, the Association for Dance Movement Psychotherapy (ADMP, UK). Similar professional bodies exist in Europe, but in some countries (e.g. China) where the profession is in development, a lower level of qualification would mirror the situation some decades previously in the USA or UK. Hence, the review authors accepted a relevant professional qualification (e.g. nursing or psychodynamic therapies) plus a clear description of the treatment that would indicate its adherence to published guidelines including Levy 1992, ADMP UK 2015, Meekums 2002, and Karkou 2006.
Data collection and analysis
Study methodological quality was evaluated and data were extracted independently by the first two review authors using a data extraction form, the third author acting as an arbitrator.
Main results
Three studies totalling 147 participants (107 adults and 40 adolescents) met the inclusion criteria. Seventy‐four participants took part in DMT treatment, while 73 comprised the control groups. Two studies included male and female adults with depression. One of these studies included outpatient participants; the other study was conducted with inpatients at an urban hospital. The third study reported findings with female adolescents in a middle‐school setting. All included studies collected continuous data using two different depression measures: the clinician‐completed Hamilton Depression Rating Scale (HAM‐D); and the Symptom Checklist‐90‐R (SCL‐90‐R) (self‐rating scale).
Statistical heterogeneity was identified between the three studies. There was no reliable effect of DMT on depression (SMD ‐0.67 95% CI ‐1.40 to 0.05; very low quality evidence). A planned subgroup analysis indicated a positive effect in adults, across two studies, 107 participants, but this failed to meet clinical significance (SMD ‐7.33 95% CI ‐9.92 to ‐4.73).
One adult study reported drop‐out rates, found to be non‐significant with an odds ratio of 1.82 [95% CI 0.35 to 9.45]; low quality evidence. One study measured social functioning, demonstrating a large positive effect (MD ‐6.80 95 % CI ‐11.44 to ‐2.16; very low quality evidence), but this result was imprecise. One study showed no effect in either direction for quality of life (0.30 95% CI ‐0.60 to 1.20; low quality evidence) or self esteem (1.70 95% CI ‐2.36 to 5.76; low quality evidence).
Authors' conclusions
The low‐quality evidence from three small trials with 147 participants does not allow any firm conclusions to be drawn regarding the effectiveness of DMT for depression. Larger trials of high methodological quality are needed to assess DMT for depression, with economic analyses and acceptability measures and for all age groups.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>25695871</pmid><doi>10.1002/14651858.CD009895.pub2</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1469-493X |
| ispartof | Cochrane database of systematic reviews, 2015-02, Vol.2016 (6), p.CD009895-CD009895 |
| issn | 1469-493X 1469-493X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8928931 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection; Cochrane Library |
| subjects | Adolescent Adult Antidepressive Agents Antidepressive Agents - therapeutic use Child & Adolescent Child health Complementary & alternative medicine Condition Dance Therapy Dance Therapy - methods Depression Depression - therapy Depressive disorder Depressive disorder, major Depressive disorders & major depression Empathy Female Humans Intervention Male Medicine General & Introductory Medical Sciences Mental health Mood disorders Movement Older people Other Population Psychotherapy Randomized Controlled Trials as Topic Sensation |
| title | Dance movement therapy for depression |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A39%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dance%20movement%20therapy%20for%20depression&rft.jtitle=Cochrane%20database%20of%20systematic%20reviews&rft.au=Meekums,%20Bonnie&rft.date=2015-02-19&rft.volume=2016&rft.issue=6&rft.spage=CD009895&rft.epage=CD009895&rft.pages=CD009895-CD009895&rft.issn=1469-493X&rft.eissn=1469-493X&rft_id=info:doi/10.1002/14651858.CD009895.pub2&rft_dat=%3Cproquest_pubme%3E1660412512%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1660412512&rft_id=info:pmid/25695871&rfr_iscdi=true |